Envoy Medical earnings were -$26.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest COCH earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$6.2M, down 18.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, COCH reported annual earnings of -$28.0M, with -10.5% growth.
Envoy Medical (NASDAQ: COCH) reported Q1 2025 earnings per share (EPS) of -$0.29, up 29.27% year over year. Total COCH earnings for the quarter were -$6.24 million. In the same quarter last year, Envoy Medical's earnings per share (EPS) was -$0.41.
As of the last Envoy Medical earnings report, Envoy Medical is currently losing money. Envoy Medical's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$19.52 million, a 14.55% decrease year over year.
What was COCH's earnings growth in the past year?
As of Envoy Medical's earnings date in Q2 2025, Envoy Medical's earnings has grown year over year. COCH earnings in the past year totalled -$26.57 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.